V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 290008309 | 290005622 | 1.6 | null | Palliative (P) | 2014-07-19 | 2014-08-11 | Cisplatin 100 + RT(H&N) 1 day | null | null | 290015201 | CAPECITABINE |
| 290008310 | 290007389 | 1.69 | 90.35 | Palliative (P) | 2019-01-16 | 2019-01-27 | CAPECITABINE + MITOMYCIN + RT | null | null | 290015541 | CAPECITABINE + GEMCITABINE |
| 290008311 | 290007397 | 1.7 | 77.7 | Palliative (P) | 2016-05-02 | 2016-05-01 | Carboplatin+Fluorouracil 4 or 5 day | 02 | N | 290017690 | DOCETAXEL |
| 290008312 | 290007404 | 1.75 | 86 | null | 2016-08-24 | 2016-10-11 | REGORAFENIB | N | N | 290020477 | CAPECITABINE |
| 290008313 | 290005658 | null | 74.4 | Palliative (P) | 2019-06-28 | 2019-06-29 | Carbo F | 2 | null | 290020732 | CARBOPLATIN + ETOPOSIDE |
| 290008314 | 290005663 | null | 0 | Palliative (P) | 2016-08-05 | 2016-08-27 | Trastuzumab Subcutaneous | Y | N | 290020936 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 290008315 | 290005665 | 1.73 | 48.5 | Palliative (P) | 2018-08-29 | 2019-02-14 | Trabectedin | 02 | N | 290021044 | CARBO + FLUOROURACIL |
| 290008316 | 290005670 | 1.75 | null | Palliative (P) | 2016-04-13 | 2016-04-17 | Capecitabine + Mitomycin | 02 | N | 290021602 | CARBOPLATIN + CETUXIMAB + FLUOROURACIL |
| 290008317 | 290005672 | 1.78 | 78.2 | Palliative (P) | 2015-11-09 | 2015-11-09 | Capecitabine | N | N | 290021740 | TRASTUZUMAB + VINORELBINE |
| 290008318 | 290005675 | 1.85 | 72 | Palliative (P) | 2016-02-25 | 2016-02-25 | Y-90 | N | N | 290021955 | NIVOLUMAB |
| 290008319 | 290005676 | 1.72 | 107.3 | Adjuvant (A) | 2017-08-04 | 2017-09-02 | Sunitinib | 2 | N | 290021968 | CAPECITABINE + CISPLATIN |
| 290008320 | 290005679 | null | 78.7 | Palliative (P) | 2019-04-13 | 2019-04-13 | Carboplatin AUC 6 - 10 | 2 | Y | 290022316 | LANREOTIDE |
| 290008321 | 290005688 | 1.62 | 66.6 | Palliative (P) | 2016-09-30 | 2016-10-08 | Cetuximab 14 day | null | Y | 290023418 | MCX |
| 290008322 | 290008078 | null | 51.7 | Palliative (P) | 2017-12-11 | 2017-12-27 | CARBOPLATIN + PACLITAXEL | 02 | N | 290024309 | LANREOTIDE |
| 290008323 | 290007426 | 1.69 | 76 | Palliative (P) | 2015-08-30 | 2016-01-12 | Carboplatin + Etoposide iv&po | 2 | N | 290024779 | CARBOPLATIN + DACARBAZINE |
| 290008324 | 290005705 | 1.85 | 103 | Neo-adjuvant (N) | 2015-11-22 | 2015-11-22 | CETUXIMAB | N | null | 290025303 | CISPLATIN |
| 290008325 | 290005720 | 1.8 | 73.1 | Palliative (P) | 2018-11-18 | 2018-12-06 | Trial Unspecified | N | N | 290026431 | CARBOPLATIN + PACLITAXEL |
| 290008326 | 290005727 | 1.52 | 76.3 | Palliative (P) | 2018-11-08 | 2018-12-17 | Cisplatin + Radiotherapy | N | N | 290026832 | CAPECITABINE + CISPLATIN |
| 290008327 | 290008084 | 1.76 | 89 | Palliative (P) | 2018-10-05 | 2019-06-08 | Capecitabine | 02 | N | 290027215 | DOCETAXEL |
| 290008328 | 290005739 | 1.72 | null | null | 2016-08-02 | 2016-08-30 | Y-90 | null | N | 290005184 | CARBOPLATIN |
| 290008329 | 290005740 | 1.62 | null | Palliative (P) | 2018-11-28 | 2018-12-05 | Capecitabine + Mitomycin | N | N | 290009412 | PANITUMUMAB |
| 290008330 | 290005746 | null | null | Palliative (P) | null | 2019-10-24 | Capecitabine + Oxaliplatin 21day | N | N | 290011095 | SUNITINIB |
| 290008331 | 290004154 | 1.68 | 61 | Curative (C) | 2014-01-06 | 2014-08-09 | FLUOROURACIL + MITOMYCIN + RT | 02 | Y | 290000126 | FLUOROURACIL + MITOMYCIN + RT |
| 290008332 | 290004187 | 1.62 | 59.3 | null | 2018-06-22 | 2018-07-18 | Fluorouracil+Mitomycin+RT (Anal Ca) | N | N | 290000823 | FLUOROURACIL + MITOMYCIN + RT |
| 290008333 | 290004214 | 1.68 | 68 | Palliative (P) | 2016-10-19 | 2016-10-27 | Irinotecan + Modified De Gramont | N | N | 290001559 | IRINOTECAN + MDG |
| 290008334 | 290004223 | 1.65 | 113 | Palliative (P) | 2017-07-25 | 2018-04-11 | CISPLATIN + FLUOROURACIL | N | null | 290001759 | CISPLATIN + FLUOROURACIL |
| 290008335 | 290006797 | null | 57.5 | Palliative (P) | 2015-02-22 | 2015-02-22 | CISPLATIN + FLUOROURACIL | N | N | 290002061 | CISPLATIN + FLUOROURACIL |
| 290008336 | 290004286 | 1.58 | 91 | Neo-adjuvant (N) | 2015-04-21 | 2015-09-22 | IMATINIB | 02 | N | 290003227 | IMATINIB |
| 290008337 | 290004289 | 1.77 | 90.9 | Palliative (P) | 2017-11-15 | 2017-12-06 | CISPLATIN + FLUOROURACIL | N | N | 290003272 | CISPLATIN + FLUOROURACIL |
| 290008338 | 290004306 | 1.63 | 78.5 | null | 2015-10-13 | 2017-05-06 | Fluorouracil 96hr infusion+R(4g/m2) | N | N | 290003696 | FLUOROURACIL |
| 290008339 | 290006829 | 1.7 | 73.3 | Palliative (P) | 2014-04-04 | 2014-04-09 | Fluorouracil 96hr infusion+R(4g/m2) | N | N | 290003884 | FLUOROURACIL |
| 290008340 | 290004328 | null | 70 | Palliative (P) | 2017-05-07 | 2018-01-22 | Irinotecan + Modified De Gramont | N | N | 290004090 | IRINOTECAN + MDG |
| 290008341 | 290004365 | 1.56 | 38.5 | Palliative (P) | 2017-07-28 | 2017-08-13 | Cisplatin +Fluorouracil (3 wk) | 02 | N | 290004850 | CISPLATIN + FLUOROURACIL |
| 290008342 | 290004384 | 1.67 | null | Palliative (P) | 2019-05-30 | 2019-08-14 | Oxaliplatin + Modified de Gramont | Y | null | 290005240 | OXALIPLATIN + MDG |
| 290008343 | 290004389 | 1.45 | 62 | Adjuvant (A) | 2014-08-15 | 2015-09-13 | Fluorouracil 96hr infusion+R(4g/m2) | N | Y | 290005417 | FLUOROURACIL |
| 290008344 | 290004416 | 1.78 | null | Palliative (P) | 2017-07-15 | 2017-08-16 | FLUOROURACIL + MITOMYCIN + RT | N | N | 290006317 | FLUOROURACIL + MITOMYCIN + RT |
| 290008345 | 290004450 | 1.71 | 70.8 | Palliative (P) | 2013-12-14 | 2013-12-14 | IMATINIB | 02 | N | 290007667 | IMATINIB |
| 290008346 | 290004468 | 1.63 | null | Palliative (P) | 2017-02-08 | 2017-03-29 | Fluorouracil+Mitomycin+RT (Anal Ca) | N | Y | 290008110 | FLUOROURACIL + MITOMYCIN + RT |
| 290008347 | 290004471 | 1.7 | null | Palliative (P) | 2019-01-26 | 2019-02-05 | Irinotecan + Modified De Gramont | N | N | 290008202 | IRINOTECAN + MDG |
| 290008348 | 290004483 | null | null | Palliative (P) | 2013-09-05 | 2016-01-15 | Fluorouracil 96hr infusion+R(4g/m2) | N | null | 290008453 | FLUOROURACIL |
| 290008349 | 290006909 | 1.7 | null | Palliative (P) | 2016-07-12 | 2016-08-03 | FLUOROURACIL + OXALIPLATIN | null | null | 290008864 | OXALIPLATIN + MDG |
| 290008350 | 290004505 | 1.64 | 73.7 | Curative (C) | null | 2013-11-07 | Fluorouracil+Mitomycin+RT (Anal Ca) | 02 | N | 290009192 | FLUOROURACIL + MITOMYCIN + RT |
| 290008351 | 290004507 | 1.81 | 64.8 | Palliative (P) | 2014-12-24 | 2015-01-08 | IMATINIB | N | N | 290009221 | IMATINIB |
| 290008352 | 290004514 | 1.6 | 86 | Palliative (P) | 2019-05-16 | 2019-05-20 | Carboplatin + Cetux + FU (>Cycle 2) | N | N | 290009278 | CAPECITABINE + CARBOPLATIN |
| 290008353 | 290004529 | 1.77 | 80.5 | Curative (C) | 2014-09-21 | 2014-10-02 | Trial Unspecified | N | null | 290009535 | CHOP R |
| 290008354 | 290004535 | 1.64 | 48 | Palliative (P) | 2015-04-17 | 2017-10-10 | ECX | N | null | 290009642 | CAPE + CARBOPLATIN + CETUXIMAB |
| 290008355 | 290004547 | null | null | null | 2013-02-01 | 2013-07-12 | Trial Unspecified | 02 | N | 290009841 | LANREOTIDE |
| 290008356 | 290004573 | 1.55 | null | Disease modification (D) | 2015-01-07 | 2015-01-07 | Trastuzumab 21 day maintenance | 2 | null | 290010594 | LANREOTIDE |
| 290008357 | 290004585 | 1.72 | null | Curative (C) | null | 2018-05-24 | CETUXIMAB | null | null | 290011038 | RITUXIMAB |
| 290008358 | 290004603 | 1.62 | 78.8 | Curative (C) | 2015-12-21 | 2016-07-31 | LANREOTIDE | N | Y | 290011622 | CISPLATIN + RT |